Oragenics, Inc. (OGEN) short interest & options flow
AMEXOragenics enters what may be its most watched week in months — Q1 results just dropped Thursday, with a second event scheduled for May 11, and the borrow market is as tight as it has been all year. Short sellers have built a formidable position. Short interest is 16.2% of the free float, or roughly 676,000 shares, even after a steady bleed lower over the past month — down about 7%…
OGEN SI utilization hits 92.62%, near 52-week peak of 100% — borrowing costs surge to 31.99% as short sellers face tight conditions.
- Market cap
- $2M
- Next earnings
- 19 Nov 2026
Key data as of 12 Nov 2026
Latest signals on OGEN
- Utilization
OGEN SI utilization hits 92.62%, near 52-week peak of 100% — borrowing costs surge to 31.99% as short sellers face tight conditions.
OGEN news and analysis
RSSNo long-form analysis yet for OGEN. Pulse alerts and the live data picture are available on ORTEX.
Open OGEN on ORTEX →Want the live picture for OGEN?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OGEN — free to start on ORTEX.
Sign up for free →Open OGEN on ORTEX